To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DHRS13andFLOT2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
535 supporting clones for gene DHRS13andFLOT2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BF530995 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1 to 740 1 to 739   tiling clone,   739/945
(78 %)
18 diff
(98.1 %id)
BX359353 Placenta Cot 25-normalized .a 24 to 825 1 to 803   tiling clone,   803/803
(100 %)
32 diff
(96.1 %id)
BX373594 Placenta Cot 25-normalized .a 1700 to 2561 863 to 1   tiling clone,   863/907
(95 %)
22 diff
(97.6 %id)
AK296017 subthalamic nucleus .b 1 to 1569 1 to 1569   tiling clone,   1569/1569
(100 %)
0 diff
(100 %id)
DC338645 subthalamic nucleus .b 1 to 546 1 to 546       546/546
(100 %)
0 diff
(100 %id)
TI_57237224   .b 1528 to 2116 31 to 620   tiling clone,   590/620
(95 %)
10 diff
(98.4 %id)
AL556179 placenta .b 1626 to 2372 1 to 751       751/929
(80 %)
33 diff
(96.5 %id)
BX342181   .b 1630 to 2624 5 to 997       993/1051
(94 %)
17 diff
(98.4 %id)
AL533430 adult brain, brain .b 1630 to 2555 1 to 924       924/924
(100 %)
9 diff
(99.1 %id)
CB960587 Human Placenta, placenta .b 1644 to 2358 25 to 746       722/785
(91 %)
18 diff
(97.8 %id)
AL530452 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .b 1652 to 2656 1 to 1003       1003/1003
(100 %)
2 diff
(99.9 %id)
BG420618 Kidney, renal cell adenocarcinoma .b 1654 to 2413 1 to 763       763/881
(86 %)
15 diff
(98.3 %id)
BX425883 neuroblastoma .b 1655 to 2661 1 to 997   tiling clone,   997/1021
(97 %)
13 diff
(98.8 %id)
BX445492 neuroblastoma .b 1655 to 2584 1 to 929       929/929
(100 %)
19 diff
(98.0 %id)
CA390100 eye, RPE/choroid .b 1656 to 2182 1 to 527       527/527
(100 %)
0 diff
(100 %id)
NM_004475.2   .b 1656 to 4286 1 to 2631 exact RefSeq, AAA   2631/2631
(100 %)
0 diff
(100 %id)
AL556473 placenta .b 1657 to 2603 1 to 946       946/946
(100 %)
4 diff
(99.6 %id)
BQ438316 leiomyosarcoma, uterus .b 1657 to 2364 1 to 708       708/867
(81 %)
6 diff
(99.4 %id)
CR979977 T-Lymphocytes .b 1658 to 2157 1 to 500       500/504
(99 %)
1 diff
(99.9 %id)
DA284287 corpus callosum .b 1664 to 2213 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
CN407631 embryonic stem cells, cell lines H1, H7, andH9 .b 1666 to 2151 1 to 486       486/486
(100 %)
0 diff
(100 %id)
BM805252 brain, hippocampus .b 1670 to 2551 13 to 894       882/1091
(80 %)
26 diff
(97.7 %id)
TI_57202507   .b 1670 to 2324 65 to 721       657/721
(91 %)
15 diff
(98.0 %id)
AL527965 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 1678 to 2602 1 to 923       923/923
(100 %)
24 diff
(97.4 %id)
CN407627 embryonic stem cells, cell lines H1, H7, andH9 .b 1681 to 2284 1 to 604       604/604
(100 %)
0 diff
(100 %id)
AL561380 B cells from Burkitt lymphoma .b 1682 to 2669 20 to 1002       983/1002
(98 %)
10 diff
(99.1 %id)
DB504079 hypothalamus .b 1682 to 2158 1 to 477       477/477
(100 %)
0 diff
(100 %id)
CN407630 embryonic stem cells, cell lines H1, H7, andH9 .b 1684 to 2281 1 to 598       598/598
(100 %)
0 diff
(100 %id)
DN995588 breast cancer, Mammary gland (cancer tissue) .b 1686 to 2409 1 to 724       724/724
(100 %)
6 diff
(99.2 %id)
BM465847 eye, retinoblastoma .b 1688 to 2456 25 to 802       778/1040
(74 %)
25 diff
(97.6 %id)
CR992808 T-Lymphocytes .b 1697 to 2524 1 to 831       831/840
(98 %)
3 diff
(99.7 %id)
CT000788 T-Lymphocytes .b 1697 to 2205 1 to 509       509/512
(99 %)
1 diff
(99.9 %id)
CN407623 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1698 to 2353 1 to 656       656/656
(100 %)
0 diff
(100 %id)
BQ231134 epithelioid carcinoma, Pancreas .b 1699 to 2364 1 to 666       666/884
(75 %)
11 diff
(98.8 %id)
BQ217852 epithelioid carcinoma, Pancreas .b 1699 to 2470 1 to 779       779/949
(82 %)
14 diff
(98.6 %id)
BU179503 epithelioid carcinoma, Pancreas .b 1701 to 2483 1 to 791       791/905
(87 %)
22 diff
(97.6 %id)
BQ059245 lymph, lymphoma, cell line .b 1702 to 2477 1 to 776       776/1075
(72 %)
9 diff
(99.2 %id)
BQ333740 marrow .b 1703 to 2209 5 to 508       504/518
(97 %)
17 diff
(96.8 %id)
BU540501 large cell carcinoma, lung .b 1703 to 2454 1 to 753       753/946
(79 %)
3 diff
(99.7 %id)
BQ062234 lymph, lymphoma, cell line .b 1704 to 2642 1 to 952       952/1030
(92 %)
26 diff
(97.5 %id)
BQ064266 lymph, lymphoma, cell line .b 1704 to 2576 1 to 888   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 888/1025
(86 %)
31 diff
(97.0 %id)
BQ643294 lymph, lymphoma, cell line .b 1704 to 2623 1 to 925       925/925
(100 %)
18 diff
(98.1 %id)
TI_57197841   .b 1704 to 2298 40 to 634       595/634
(93 %)
7 diff
(98.9 %id)
BQ919337 large cell carcinoma, lung .b 1712 to 2552 1 to 841       841/908
(92 %)
8 diff
(99.2 %id)
BQ710499 Spleen .b 1717 to 2541 1 to 825       825/921
(89 %)
9 diff
(99.1 %id)
BG819870 anaplastic oligodendroglioma with 1p/19qloss, brain .b 1725 to 2420 1 to 696       696/696
(100 %)
2 diff
(99.8 %id)
AL546516 placenta, Placenta Cot 25-normalized .b 1727 to 2692 1 to 964       964/964
(100 %)
5 diff
(99.5 %id)
BQ959215 epidermoid carcinoma, cell line, lung .b 1735 to 2087 1 to 356       356/809
(44 %)
11 diff
(98.7 %id)
AL540765 placenta .b 1737 to 2696 1 to 962       962/1112
(86 %)
9 diff
(99.2 %id)
BX445631 placenta .b 1737 to 2610 1 to 874       874/874
(100 %)
3 diff
(99.7 %id)
ES314304 occipital scalp hair, skin .b 1737 to 1904 1 to 167       167/167
(100 %)
1 diff
(99.5 %id)
BG024681 lymph, lymphoma, cell line .b 1740 to 2433 1 to 693       693/694
(99 %)
6 diff
(99.2 %id)
BM479624 embryonal carcinoma, cell line, testis .b 1740 to 2567 1 to 831       831/1075
(77 %)
24 diff
(97.8 %id)
CD517542 White Matter .b 1740 to 2477 25 to 766       742/853
(86 %)
14 diff
(98.4 %id)
BG420320 Kidney, renal cell adenocarcinoma .b 1743 to 2338 1 to 597       597/597
(100 %)
2 diff
(99.7 %id)
CN407632 embryonic stem cells, cell lines H1, H7, andH9 .b 1744 to 2043 1 to 300       300/300
(100 %)
1 diff
(99.7 %id)
TI_57178504   .b 1748 to 2316 26 to 596       571/931
(61 %)
23 diff
(97.6 %id)
BI769152 pooled lung and spleen .b 1753 to 2316 1 to 566       566/901
(62 %)
13 diff
(98.6 %id)
BQ439134 large cell carcinoma, lung .b 1754 to 2358 1 to 608       608/972
(62 %)
15 diff
(98.5 %id)
BQ878546 dorsal root ganglia .b 1755 to 2543 1 to 794       794/881
(90 %)
12 diff
(98.7 %id)
BG489741 large cell carcinoma, lung .b 1757 to 2327 7 to 593       587/1266
(46 %)
27 diff
(97.9 %id)
AW675382 cervical carcinoma cell line, cervix .b 1764 to 2260 1 to 497       497/497
(100 %)
17 diff
(96.6 %id)
BE548438 cervical carcinoma cell line, cervix .b 1764 to 2452 1 to 690       690/780
(88 %)
8 diff
(99.0 %id)
AA085017   .b 1767 to 2125 1 to 365       365/368
(99 %)
15 diff
(96.0 %id)
BU930879 ovary, teratocarcinoma, cell line .b 1774 to 2661 1 to 898       898/928
(96 %)
14 diff
(98.5 %id)
BU930884 ovary, teratocarcinoma, cell line .b 1774 to 2453 1 to 690       690/856
(80 %)
18 diff
(97.9 %id)
TI_1948124221   .b 1778 to 2705 127 to 1056       930/1213
(76 %)
32 diff
(97.4 %id)
TI_1948124222   .b 1778 to 2477 127 to 827       701/1369
(51 %)
17 diff
(98.8 %id)
TI_1948124742   .b 1778 to 2698 127 to 1051       925/1225
(75 %)
26 diff
(97.9 %id)
TI_1948124743   .b 1778 to 2628 126 to 969       844/1366
(61 %)
36 diff
(97.4 %id)
TI_1948124744   .b 1778 to 2651 133 to 1014       882/1317
(66 %)
31 diff
(97.7 %id)
TI_1948125281   .b 1778 to 2701 124 to 1045       922/1142
(80 %)
22 diff
(98.1 %id)
TI_1948125282   .b 1778 to 2711 129 to 1061       933/1330
(70 %)
35 diff
(97.4 %id)
TI_1948125810   .b 1778 to 2765 126 to 1121       993/1151
(86 %)
30 diff
(97.4 %id)
TI_1948125811   .b 1778 to 2474 125 to 827       703/1437
(48 %)
24 diff
(98.4 %id)
CV029855 mixed .b 1779 to 2295 1 to 518       518/518
(100 %)
2 diff
(99.7 %id)
TI_1948125283   .b 1779 to 2477 128 to 827       700/1293
(54 %)
13 diff
(99.0 %id)
TI_1948124223   .b 1781 to 2646 135 to 1001       867/1257
(68 %)
40 diff
(96.9 %id)
CN407626 embryonic stem cells, DMSO-treated H9 cellline .b 1797 to 2270 1 to 474       474/474
(100 %)
0 diff
(100 %id)
M60922 epidermis .b 1800 to 4286 1 to 2487       2487/2488
(99 %)
3 diff
(99.9 %id)
BE831312 marrow .b 1810 to 2066 1 to 256       256/256
(100 %)
1 diff
(99.7 %id)
BE831305 marrow .b 1831 to 2125 21 to 315       295/361
(81 %)
8 diff
(97.8 %id)
BC017292 Pancreas, epithelioid carcinoma .b 1834 to 4286 1 to 2453   tiling clone, available from MGC, AAA   2453/2453
(100 %)
1 diff
(100.0 %id)
BG832070 epithelioid carcinoma cell line, Pancreas .b 1848 to 2699 1 to 861   available from MGC,   861/897
(95 %)
40 diff
(95.6 %id)
BU542095 carcinoma, cell line, Prostate .b 1852 to 2700 1 to 852       852/887
(96 %)
12 diff
(98.7 %id)
BG025687 lymph, lymphoma, cell line .b 1862 to 2416 13 to 571       559/575
(97 %)
13 diff
(97.8 %id)
BM925812 brain .b 1868 to 2722 14 to 873       856/1062
(80 %)
14 diff
(98.7 %id)
BM413649 eye, retinoblastoma .b 1879 to 2576 23 to 725       703/947
(74 %)
13 diff
(98.7 %id)
CN407622 embryonic stem cells, DMSO-treated H9 cellline .b 1884 to 2222 1 to 339       339/339
(100 %)
0 diff
(100 %id)
BG423240 Kidney, renal cell adenocarcinoma .b 1887 to 2116 1 to 230       230/230
(100 %)
1 diff
(99.6 %id)
CT002541 T-Lymphocytes .b 1893 to 2551 1 to 662       662/666
(99 %)
4 diff
(99.4 %id)
BE873197 adenocarcinoma, colon .b 1903 to 2662 1 to 761       761/776
(98 %)
21 diff
(97.3 %id)
BU153654 epithelioid carcinoma, Pancreas .b 1906 to 2698 1 to 795       795/860
(92 %)
8 diff
(99.1 %id)
TI_1948085791   .b 1919 to 2477 121 to 679       559/1420
(39 %)
5 diff
(99.7 %id)
TI_1948085947   .b 1919 to 2546 123 to 750   fully sequenced,   628/750
(83 %)
6 diff
(99.2 %id)
TI_1948086106   .b 1919 to 2433 123 to 637   fully sequenced,   515/637
(80 %)
5 diff
(99.3 %id)
BT019477   .b 1926 to 3063 1 to 1138       1138/1140
(99 %)
1 diff
(100.0 %id)
BT019478   .b 1926 to 3063 1 to 1138       1138/1140
(99 %)
1 diff
(100.0 %id)
CR541784   .b 1926 to 3062 1 to 1137       1137/1137
(100 %)
0 diff
(100 %id)
CR542265   .b 1926 to 3065 1 to 1140       1140/1140
(100 %)
0 diff
(100 %id)
CV029108 mixed .b 1926 to 2500 1 to 575       575/575
(100 %)
4 diff
(99.4 %id)
CV329266 nervous_tumor .b 1948 to 2213 1 to 266       266/275
(96 %)
4 diff
(98.6 %id)
CV321702 placenta_normal .b 1966 to 2330 1 to 365       365/369
(98 %)
1 diff
(99.8 %id)
BQ053361 blood, natural killer cells, cell line .b 1981 to 2874 1 to 902       902/1010
(89 %)
32 diff
(96.9 %id)
BG325674 Kidney, renal cell adenocarcinoma .b 1986 to 2643 1 to 656       656/941
(69 %)
4 diff
(99.6 %id)
BM477245 lymph, lymphoma, cell line .b 2001 to 3025 1 to 1029       1029/1099
(93 %)
25 diff
(97.8 %id)
BI818509 pooled brain, lung, testis .b 2011 to 2821 1 to 813       813/815
(99 %)
14 diff
(98.3 %id)
TI_57196403   .b 2011 to 2821 38 to 850       813/852
(95 %)
20 diff
(97.7 %id)
BE743640 adenocarcinoma cell line, ovary .b 2033 to 2620 1 to 592       592/592
(100 %)
7 diff
(98.9 %id)
BG830458 epithelioid carcinoma cell line, Pancreas .b 2059 to 2604 34 to 573       540/574
(94 %)
11 diff
(98.1 %id)
BQ424665 melanotic melanoma, skin .b 2063 to 2910 1 to 858       858/957
(89 %)
21 diff
(97.9 %id)
BM917108 blood, natural killer cells, cell line .b 2077 to 3026 1 to 951       951/1087
(87 %)
7 diff
(99.4 %id)
BM457499 embryonal carcinoma, cell line, testis .b 2086 to 2960 1 to 884       882/1063
(82 %)
21 diff
(98.1 %id)
BU186280 embryonal carcinoma, cell line, testis .b 2096 to 2874 1 to 784       784/861
(91 %)
10 diff
(98.9 %id)
CR735229 blood, natural killer cells, cell line .b 2106 to 2619 33 to 546       514/546
(94 %)
6 diff
(99.0 %id)
AA366736 Pancreas .b 2155 to 2427 1 to 274       274/274
(100 %)
4 diff
(98.6 %id)
CV323879 colon_normal .b 2166 to 2559 393 to 2     Submitted on the opposite strand 392/393
(99 %)
3 diff
(99.3 %id)
CX787227 human embryonic stem cells .b 2166 to 2950 1 to 784       784/784
(100 %)
1 diff
(99.9 %id)
ES309852 scalp interfollicular dermis, skin .b 2186 to 2556 1 to 372       370/372
(99 %)
13 diff
(96.6 %id)
BE245399 leukopheresis .b 2196 to 2803 607 to 1       607/607
(100 %)
2 diff
(99.7 %id)
AL037032 brain .b 2202 to 2859 1 to 664       664/667
(99 %)
12 diff
(98.3 %id)
BM473765 melanotic melanoma, skin .b 2204 to 3310 1 to 1099       1099/1100
(99 %)
40 diff
(96.4 %id)
BM044960 carcinoma, cell line, Prostate .b 2216 to 3024 1 to 804       804/807
(99 %)
19 diff
(97.7 %id)
BM044480 carcinoma, cell line, Prostate .b 2220 to 2966 1 to 750       750/750
(100 %)
3 diff
(99.6 %id)
BE273352 Kidney, renal cell adenocarcinoma .b 2221 to 2811 1 to 589       589/669
(88 %)
15 diff
(97.8 %id)
CN407621 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2222 to 2999 1 to 778       778/778
(100 %)
0 diff
(100 %id)
BQ958934 carcinoma, cell line, Prostate .b 2222 to 3015 1 to 805       805/956
(84 %)
13 diff
(98.7 %id)
BQ952505 carcinoma, cell line, Prostate .b 2222 to 2875 1 to 665       665/1314
(50 %)
12 diff
(99.1 %id)
BI093594 cervix .b 2238 to 2942 1 to 709       709/709
(100 %)
9 diff
(98.8 %id)
CD359841 testis .b 2238 to 2819 75 to 676       615/1037
(59 %)
71 diff
(93.2 %id)
CN407625 embryonic stem cells, cell lines H1, H7, andH9 .b 2239 to 2956 1 to 718       718/718
(100 %)
2 diff
(99.8 %id)
AI902946 breast .b 2242 to 2723 1 to 482       482/482
(100 %)
10 diff
(98.0 %id)
CA455346 adenocarcinoma, cell line, breast .b 2255 to 3119 1 to 878       875/881
(99 %)
27 diff
(97.0 %id)
AI902880 breast .b 2267 to 2743 9 to 485       477/486
(98 %)
28 diff
(94.3 %id)
BF094067 uterus_tumor .b 2273 to 2466 225 to 32       194/226
(85 %)
2 diff
(99.2 %id)
BG391328 embryonal carcinoma, cell line, testis .b 2276 to 2749 1 to 474       474/475
(99 %)
1 diff
(99.8 %id)
BF326224 amnion_normal .b 2278 to 2458 181 to 1       181/183
(98 %)
4 diff
(97.9 %id)
CV334570 uterus_tumor .b 2282 to 2593 312 to 1     Submitted on the opposite strand 312/312
(100 %)
0 diff
(100 %id)
BF869290 lung_tumor .b 2325 to 2593 269 to 1     Submitted on the opposite strand 269/269
(100 %)
1 diff
(99.7 %id)
TI_1948086107   .b 2403 to 3064 783 to 121   fully sequenced,   663/783
(84 %)
1 diff
(99.9 %id)
CX786339 human embryonic stem cells .b 2420 to 3172 1 to 753       753/753
(100 %)
0 diff
(100 %id)
BQ224085 embryonal carcinoma, cell line, testis .b 2423 to 3227 1 to 817       817/895
(91 %)
17 diff
(98.2 %id)
BM743196 stomach .b 2424 to 3088 1 to 665       665/665
(100 %)
0 diff
(100 %id)
TI_57231627   .b 2425 to 3172 40 to 805       766/817
(93 %)
42 diff
(94.9 %id)
BI053742 placenta_normal .b 2445 to 2593 149 to 1       149/149
(100 %)
0 diff
(100 %id)
BG774912 carcinoma, cell line, Prostate .b 2448 to 3308 1 to 858       858/858
(100 %)
11 diff
(98.8 %id)
BM044372 carcinoma, cell line, Prostate .b 2448 to 3203 1 to 759       757/928
(81 %)
15 diff
(98.4 %id)
BM047629 carcinoma, cell line, Prostate .b 2448 to 3220 1 to 772       772/915
(84 %)
19 diff
(98.0 %id)
CX782938 human embryonic stem cells .b 2450 to 3286 1 to 836       836/836
(100 %)
6 diff
(99.3 %id)
BQ927707 carcinoma, cell line, Prostate .b 2451 to 3155 1 to 714       714/795
(89 %)
15 diff
(98.2 %id)
BU541464 carcinoma, cell line, Prostate .b 2451 to 3351 1 to 911       911/920
(99 %)
21 diff
(97.8 %id)
BQ376965 uterus .b 2476 to 2869 17 to 411       396/411
(96 %)
6 diff
(98.6 %id)
TI_1948085792   .b 2476 to 3064 712 to 122       591/1387
(42 %)
4 diff
(99.8 %id)
BU179554 large cell carcinoma, lung .b 2477 to 3312 1 to 850       850/852
(99 %)
26 diff
(97.0 %id)
DA340592 hippocampus .b 2492 to 3083 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
TI_154187981   .b 2493 to 3221 98 to 827       730/1028
(71 %)
48 diff
(95.4 %id)
CB117585 brain .b 2501 to 3038 1 to 538       538/538
(100 %)
0 diff
(100 %id)
CB152272 brain .b 2501 to 3037 1 to 537       537/537
(100 %)
0 diff
(100 %id)
DA041894 bladder .b 2502 to 3058 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
TI_1948085642   .b 2502 to 3064 714 to 144       571/1465
(38 %)
20 diff
(98.7 %id)
TI_1948085948   .b 2516 to 3064 678 to 124   fully sequenced,   555/678
(81 %)
13 diff
(98.1 %id)
EC528221 Prostate .b 2532 to 2619 1 to 88       88/88
(100 %)
4 diff
(95.5 %id)
CF786009 mixed .b 2541 to 3370 1 to 826       826/830
(99 %)
14 diff
(98.4 %id)
BQ924618 large cell carcinoma, lung .b 2557 to 3384 17 to 857       841/958
(87 %)
32 diff
(96.7 %id)
BP269696 thyroid .b 2582 to 3160 1 to 579       579/579
(100 %)
0 diff
(100 %id)
CU454430 epidermis .b 2585 to 3227 659 to 17     Submitted on the opposite strand 643/659
(97 %)
2 diff
(99.7 %id)
CR977630 T-Lymphocytes .b 2592 to 3328 1 to 743       743/765
(97 %)
10 diff
(98.7 %id)
BQ895906 carcinoma, cell line, Prostate .b 2595 to 3318 1 to 733       733/991
(73 %)
21 diff
(97.9 %id)
CN407624 embryonic stem cells, DMSO-treated H9 cellline .b 2596 to 3377 1 to 782       782/782
(100 %)
3 diff
(99.7 %id)
BI053741 placenta_normal .b 2608 to 2876 271 to 5       267/271
(98 %)
2 diff
(99.3 %id)
BI060116 uterus_tumor .b 2608 to 2871 264 to 1       264/264
(100 %)
0 diff
(100 %id)
AK225491 thyroid .b 2626 to 4286 1 to 1661   tiling clone, AAA   1661/1661
(100 %)
1 diff
(100.0 %id)
BQ929323 leiomyosarcoma, uterus .b 2638 to 3561 1 to 929       929/929
(100 %)
23 diff
(97.6 %id)
EC582772 Prostate .b 2644 to 2738 1 to 95       95/95
(100 %)
0 diff
(100 %id)
CV356835 kidney_tumor .b 2659 to 3267 611 to 4     Submitted on the opposite strand 608/611
(99 %)
6 diff
(99.1 %id)
BF902680 marrow .b 2670 to 2876 207 to 2     Submitted on the opposite strand 206/210
(98 %)
0 diff
(100 %id)
BX436539 thymus .b 2693 to 3653 1 to 952       952/980
(97 %)
24 diff
(97.6 %id)
BG119854 adenocarcinoma, cell line, Liver .b 2699 to 3401 1 to 704       704/823
(85 %)
7 diff
(99.2 %id)
BG476898 melanotic melanoma, skin .b 2703 to 3534 1 to 833       833/833
(100 %)
13 diff
(98.5 %id)
CV337665 marrow .b 2728 to 3051 1 to 324       324/324
(100 %)
26 diff
(92.0 %id)
BQ317851 colon .b 2746 to 3304 559 to 1       559/568
(98 %)
3 diff
(99.5 %id)
BF892516 marrow .b 2769 to 3225 487 to 12     Submitted on the opposite strand 476/503
(94 %)
21 diff
(95.9 %id)
BQ879552 dorsal root ganglia .b 2773 to 3594 1 to 832       832/899
(92 %)
14 diff
(98.5 %id)
BF892539 marrow .b 2774 to 3225 462 to 12     Submitted on the opposite strand 451/462
(97 %)
4 diff
(99.2 %id)
BF892523 marrow .b 2782 to 3221 444 to 1     Submitted on the opposite strand 444/452
(98 %)
16 diff
(96.5 %id)
CV375404 marrow .b 2783 to 3184 460 to 51     Submitted on the opposite strand 408/460
(88 %)
11 diff
(97.7 %id)
BI009135 kidney_tumor .b 2788 to 3063 286 to 5       282/293
(96 %)
13 diff
(95.6 %id)
AW603499 colon_normal .b 2790 to 3319 530 to 1       530/530
(100 %)
9 diff
(98.4 %id)
TI_159695202   .b 2804 to 3611 53 to 861     Submitted on the opposite strand 809/1071
(75 %)
15 diff
(98.6 %id)
BQ887752 brain, neuroblastoma, cell line .b 2814 to 3752 1 to 950       950/957
(99 %)
19 diff
(98.1 %id)
BG388174 embryonal carcinoma, cell line, testis .b 2821 to 3726 1 to 903       903/946
(95 %)
34 diff
(96.5 %id)
BI017901 lung_tumor .b 2837 to 3186 428 to 76       353/428
(82 %)
3 diff
(99.3 %id)
AA464370 ovarian tumor, ovary .b 2839 to 3273 1 to 434       434/434
(100 %)
7 diff
(98.4 %id)
CD556929 brain, Pituitary .b 2842 to 3627 1 to 795       795/884
(89 %)
17 diff
(98.1 %id)
CD518007 White Matter .b 2842 to 3582 1 to 744       744/924
(80 %)
13 diff
(98.6 %id)
AW405801 lymph .b 2862 to 3419 4 to 560       557/560
(99 %)
6 diff
(99.0 %id)
TI_154143234   .b 2867 to 3577 92 to 809       718/719
(99 %)
11 diff
(98.5 %id)
BF763028 colon_est .b 2868 to 3100 233 to 1     Submitted on the opposite strand 233/233
(100 %)
2 diff
(99.2 %id)
BF764996 colon_est .b 2872 to 3012 143 to 3     Submitted on the opposite strand 141/147
(95 %)
0 diff
(100 %id)
BF765011 colon_est .b 2872 to 3104 243 to 11     Submitted on the opposite strand 233/247
(94 %)
5 diff
(98.0 %id)
BF765013 colon_est .b 2872 to 3075 204 to 1     Submitted on the opposite strand 204/208
(98 %)
8 diff
(96.2 %id)
BQ335737 marrow .b 2872 to 3258 388 to 1       388/392
(98 %)
6 diff
(98.5 %id)
BX376884 Neuroblastoma Cot 50-normalized .b 2872 to 3763 1 to 891       891/891
(100 %)
15 diff
(98.4 %id)
BF765032 colon_est .b 2875 to 3097 226 to 4     Submitted on the opposite strand 223/233
(95 %)
1 diff
(99.6 %id)
BM462369 leiomyosarcoma, uterus .b 2884 to 3757 1 to 892   AAA   892/1048
(85 %)
26 diff
(97.6 %id)
BQ681071 melanotic melanoma, cell line, skin .b 2893 to 3607 1 to 716       716/967
(74 %)
32 diff
(96.7 %id)
BF769668 epid_tumor .b 2911 to 3305 395 to 1     Submitted on the opposite strand 395/396
(99 %)
1 diff
(99.8 %id)
BI017784 lung_tumor .b 2917 to 3428 529 to 23       507/529
(95 %)
0 diff
(100 %id)
T60964 Liver .b 2925 to 3038 18 to 132       115/132
(87 %)
6 diff
(95.5 %id)
BQ072007 brain, neuroblastoma, cell line .b 2945 to 3800 1 to 877       877/1046
(83 %)
42 diff
(96.0 %id)
BU191557 epidermoid carcinoma, cell line, salivary gland .b 2945 to 3784 1 to 849       849/861
(98 %)
17 diff
(98.1 %id)
BG012160 placenta_normal .b 2948 to 3272 325 to 1       325/325
(100 %)
1 diff
(99.7 %id)
BI010597 lung_normal .b 2948 to 3272 325 to 1       325/325
(100 %)
1 diff
(99.7 %id)
BI062724 uterus_tumor .b 2962 to 3323 362 to 1       362/362
(100 %)
5 diff
(98.7 %id)
GD143260   .b 3003 to 3125 8 to 130       123/153
(80 %)
8 diff
(94.8 %id)
BI023228 marrow .b 3013 to 3199 199 to 15       185/199
(92 %)
0 diff
(100 %id)
BI017942 lung_tumor .b 3028 to 3399 418 to 49       370/419
(88 %)
0 diff
(100 %id)
CD245730 White Matter .b 3045 to 3819 1 to 788       788/889
(88 %)
18 diff
(98.0 %id)
BG002535 placenta_normal .b 3048 to 3243 201 to 7       195/206
(94 %)
0 diff
(100 %id)
AA937548 adenocarcinoma, colon .b 3123 to 3379 274 to 18     Submitted on the opposite strand 257/274
(93 %)
0 diff
(100 %id)
BI259195 cervical carcinoma cell line, cervix .b 3131 to 4006 1 to 891       891/892
(99 %)
22 diff
(97.6 %id)
BG323537 Kidney, renal cell adenocarcinoma .b 3133 to 3911 1 to 775       775/931
(83 %)
21 diff
(97.8 %id)
CR608595 fetal brain .b 3140 to 4260 1 to 1121       1121/1121
(100 %)
0 diff
(100 %id)
BF345247 anaplastic oligodendroglioma with 1p/19qloss, brain .b 3140 to 3890 1 to 751       751/860
(87 %)
23 diff
(97.4 %id)
BI091883 cervix .b 3160 to 3892 1 to 729       729/730
(99 %)
8 diff
(99.0 %id)
BX425882 neuroblastoma .b 3162 to 4259 1082 to 1       1082/1100
(98 %)
0 diff
(100 %id)
AL563747 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .b 3212 to 4271 1059 to 1       1059/1059
(100 %)
4 diff
(99.7 %id)
BQ108562 hepatocellular carcinoma, cell line, Liver .b 3222 to 3918 1 to 697       697/697
(100 %)
8 diff
(98.9 %id)
BI252117 hepatocellular carcinoma, cell line, Liver .b 3225 to 3621 1 to 388   fully sequenced,   388/388
(100 %)
2 diff
(99.5 %id)
BM006204 hepatocellular carcinoma, cell line, Liver .b 3225 to 3985 1 to 777       777/781
(99 %)
24 diff
(97.0 %id)
AL568583 placenta .b 3226 to 4243 1016 to 8       1009/1039
(97 %)
0 diff
(100 %id)
BQ647592 hepatocellular carcinoma, cell line, Liver .b 3226 to 4120 18 to 919       902/919
(98 %)
6 diff
(99.4 %id)
TI_59386160   .b 3226 to 3985 105 to 880       776/780
(99 %)
24 diff
(97.0 %id)
AL582697 B cells from Burkitt lymphoma .b 3233 to 4242 1016 to 11       1006/1016
(99 %)
0 diff
(100 %id)
AL571840 placenta, Placenta Cot 25-normalized .b 3240 to 4258 1015 to 1       1015/1018
(99 %)
13 diff
(98.8 %id)
AL578488 placenta .b 3243 to 4227 1016 to 40       977/1016
(96 %)
0 diff
(100 %id)
AL578720 placenta .b 3251 to 4231 994 to 17       978/994
(98 %)
0 diff
(100 %id)
AL527964 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 3255 to 4258 990 to 1       990/993
(99 %)
33 diff
(96.7 %id)
BX445491 neuroblastoma .b 3264 to 4260 995 to 1       995/995
(100 %)
34 diff
(96.6 %id)
AL565120 adult brain, brain .b 3267 to 4247 984 to 8       977/985
(99 %)
0 diff
(100 %id)
TI_154111690   .b 3269 to 4286 1090 to 87   AAA   1004/1012
(99 %)
22 diff
(97.9 %id)
BF362903 nervous_normal .b 3271 to 3471 203 to 2       202/218
(92 %)
6 diff
(97.3 %id)
BF362910 nervous_normal .b 3271 to 3467 210 to 13       198/225
(88 %)
0 diff
(100 %id)
CB146225 Liver .b 3272 to 3741 1 to 470       470/470
(100 %)
0 diff
(100 %id)
AL524283 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 3290 to 4285 1 to 991       991/991
(100 %)
6 diff
(99.4 %id)
BU934246 mixed (pool of 40 RNAs) .b 3297 to 4030 1 to 743       743/807
(92 %)
28 diff
(96.6 %id)
BG674544 skin .b 3299 to 4112 1 to 811       811/811
(100 %)
12 diff
(98.6 %id)
BI222336 cervical carcinoma cell line, cervix .b 3300 to 3834 1 to 535       535/535
(100 %)
0 diff
(100 %id)
BM786669 Ascites, stomach .b 3322 to 3908 1 to 587       587/587
(100 %)
0 diff
(100 %id)
AW297511   .b 3323 to 3536 1 to 214     Submitted on the opposite strand 214/217
(98 %)
10 diff
(95.4 %id)
AW297559   .b 3323 to 3536 1 to 214     Submitted on the opposite strand 214/217
(98 %)
10 diff
(95.4 %id)
CX788495 human embryonic stem cells .b 3330 to 4092 17 to 779       763/779
(97 %)
6 diff
(99.3 %id)
BX445630 placenta .b 3333 to 4271 935 to 1       935/935
(100 %)
19 diff
(98.0 %id)
BF528349 anaplastic oligodendroglioma with 1p/19qloss, brain .b 3335 to 4110 7 to 782       776/807
(96 %)
18 diff
(97.8 %id)
BF529783 anaplastic oligodendroglioma with 1p/19qloss, brain .b 3335 to 4103 7 to 763       757/922
(82 %)
27 diff
(97.1 %id)
TI_151766390   .b 3336 to 3900 103 to 687       585/892
(65 %)
66 diff
(92.7 %id)
BM704725 eye, RPE and Choroid .b 3336 to 3888 1 to 553   fully sequenced,   553/553
(100 %)
1 diff
(99.9 %id)
AW365717 head_neck .b 3344 to 3860 532 to 13       520/532
(97 %)
0 diff
(100 %id)
AW365602 head_neck .b 3348 to 3868 522 to 5       518/522
(99 %)
0 diff
(100 %id)
AW365632 head_neck .b 3349 to 3865 528 to 7       522/528
(98 %)
0 diff
(100 %id)
AW365569 head_neck .b 3352 to 3873 526 to 1       526/526
(100 %)
22 diff
(95.9 %id)
AW365611 head_neck .b 3356 to 3868 516 to 5       512/516
(99 %)
0 diff
(100 %id)
AW365790 head_neck .b 3372 to 3874 527 to 2       526/527
(99 %)
0 diff
(100 %id)
BQ278530 mixed (pool of 40 RNAs) .b 3379 to 4147 1 to 772       772/951
(81 %)
13 diff
(98.7 %id)
CV366810 amnion_normal .b 3405 to 3699 323 to 27     Submitted on the opposite strand 297/337
(88 %)
0 diff
(100 %id)
AA044792 uterus .b 3405 to 3839 1 to 430   fully sequenced,   430/430
(100 %)
1 diff
(99.8 %id)
BQ710752 Spleen .b 3410 to 4286 1 to 896       896/905
(99 %)
39 diff
(95.7 %id)
BE720210 head_neck .b 3412 to 3693 284 to 1       284/284
(100 %)
7 diff
(97.6 %id)
TI_149298090   .b 3414 to 4286 943 to 85   AAA   859/943
(91 %)
14 diff
(98.6 %id)
EC454155 Prostate .b 3424 to 3503 81 to 1       81/86
(94 %)
4 diff
(95.4 %id)
EC468893 Prostate .b 3424 to 3487 74 to 10       65/81
(80 %)
0 diff
(100 %id)
EC477894 Prostate .b 3424 to 3497 78 to 4       75/84
(89 %)
6 diff
(92.9 %id)
EC482200 Prostate .b 3424 to 3515 97 to 5       93/98
(94 %)
0 diff
(100 %id)
EC523244 Prostate .b 3424 to 3515 93 to 4       90/95
(94 %)
0 diff
(100 %id)
EC537710 Prostate .b 3424 to 3515 93 to 3       91/95
(95 %)
0 diff
(100 %id)
EC555766 Prostate .b 3424 to 3509 91 to 5       87/98
(88 %)
0 diff
(100 %id)
EC454160 Prostate .b 3428 to 3520 93 to 1       93/95
(97 %)
0 diff
(100 %id)
BM693331 eye, Retina Foveal and Macular .b 3428 to 3781 1 to 354   fully sequenced,   354/354
(100 %)
0 diff
(100 %id)
BM917069 blood, natural killer cells, cell line .b 3429 to 4286 1 to 869   AAA   869/869
(100 %)
18 diff
(98.0 %id)
BU839612 hepatocellular carcinoma, cell line, Liver .b 3429 to 4285 1 to 860   AAA   860/860
(100 %)
12 diff
(98.7 %id)
EC570554 Prostate .b 3430 to 3525 92 to 1       92/92
(100 %)
4 diff
(95.7 %id)
EC453464 Prostate .b 3431 to 3525 99 to 2       98/99
(98 %)
0 diff
(100 %id)
BM768280 stomach .b 3442 to 4091 1 to 650       650/650
(100 %)
0 diff
(100 %id)
EC548926 Prostate .b 3450 to 3542 93 to 1       93/93
(100 %)
1 diff
(99.0 %id)
BM824468 Ascites, stomach .b 3453 to 3991 1 to 539       539/539
(100 %)
0 diff
(100 %id)
TI_149313738   .b 3455 to 4286 929 to 106   AAA   824/971
(84 %)
21 diff
(97.9 %id)
TI_154117503   .b 3460 to 4285 929 to 109   AAA   821/956
(85 %)
16 diff
(98.4 %id)
EC524228 Prostate .b 3462 to 3574 112 to 1       112/112
(100 %)
2 diff
(98.3 %id)
EC474452 Prostate .b 3468 to 3572 113 to 8       106/113
(93 %)
0 diff
(100 %id)
BG775375 carcinoma, cell line, Prostate .b 3468 to 4238 771 to 1       771/775
(99 %)
8 diff
(99.0 %id)
EC564495 Prostate .b 3470 to 3577 1 to 108       108/108
(100 %)
0 diff
(100 %id)
BF207364 brain, neuroblastoma .b 3475 to 4242 1 to 756       756/770
(98 %)
13 diff
(98.4 %id)
EC476988 Prostate .b 3486 to 3592 107 to 1       107/107
(100 %)
0 diff
(100 %id)
EC505696 Prostate .b 3486 to 3593 108 to 1       108/108
(100 %)
1 diff
(99.1 %id)
EC520809 Prostate .b 3486 to 3592 106 to 1       106/106
(100 %)
1 diff
(99.1 %id)
BX374172   .b 3487 to 4284 808 to 1       808/865
(93 %)
23 diff
(97.4 %id)
BU162377 leiomyosarcoma, uterus .b 3490 to 4286 828 to 27   AAA Submitted on the opposite strand 802/809
(99 %)
33 diff
(96.0 %id)
TI_149310476   .b 3503 to 4286 869 to 88   AAA   782/950
(82 %)
11 diff
(98.9 %id)
EC513137 Prostate .b 3504 to 3609 104 to 1       104/106
(98 %)
5 diff
(95.3 %id)
BI258106 cervical carcinoma cell line, cervix .b 3507 to 4269 1 to 765       765/780
(98 %)
6 diff
(99.3 %id)
TI_154115873   .b 3513 to 4286 853 to 87   AAA   767/799
(95 %)
12 diff
(98.5 %id)
EC469016 Prostate .b 3515 to 3618 104 to 1       104/104
(100 %)
1 diff
(99.1 %id)
EC487263 Prostate .b 3515 to 3618 104 to 1       104/104
(100 %)
1 diff
(99.1 %id)
TI_149315502   .b 3518 to 4286 870 to 106   AAA   765/980
(78 %)
6 diff
(99.4 %id)
BG333327 large cell carcinoma, lung .b 3523 to 4285 1 to 755   AAA   755/755
(100 %)
11 diff
(98.6 %id)
TI_154109325   .b 3525 to 4286 849 to 92   AAA   758/937
(80 %)
8 diff
(99.2 %id)
EC460799 Prostate .b 3542 to 3645 104 to 1       104/104
(100 %)
0 diff
(100 %id)
EC446758 Prostate .b 3548 to 3644 92 to 1       92/96
(95 %)
4 diff
(95.9 %id)
BG002165 placenta_normal .b 3561 to 4161 613 to 12       602/641
(93 %)
0 diff
(100 %id)
BM708733 eye, RPE and Choroid .b 3563 to 4083 1 to 521       521/521
(100 %)
0 diff
(100 %id)
CA448508 Chondrosarcoma, Left Pelvis .b 3563 to 4286 742 to 19   AAA   724/724
(100 %)
0 diff
(100 %id)
EC442416 Prostate .b 3580 to 3675 1 to 92       92/92
(100 %)
4 diff
(95.7 %id)
BI252736 hepatocellular carcinoma, cell line, Liver .b 3591 to 4239 649 to 1   fully sequenced,   649/649
(100 %)
12 diff
(98.2 %id)
EC565081 Prostate .b 3592 to 3684 95 to 3       93/99
(93 %)
0 diff
(100 %id)
BQ015384 Chondrosarcoma, Left Pubic Bone .b 3598 to 4286 707 to 19   AAA   689/689
(100 %)
0 diff
(100 %id)
BU688770 lung .b 3602 to 4286 703 to 19   AAA   685/685
(100 %)
0 diff
(100 %id)
CA308376 Alveolar Macrophage, lung .b 3602 to 4286 703 to 19   AAA   685/685
(100 %)
0 diff
(100 %id)
BQ009647 Chondrosarcoma, Left Pubic Bone .b 3604 to 4286 701 to 19   AAA   683/683
(100 %)
0 diff
(100 %id)
BU684544 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 3604 to 4286 701 to 19   AAA   683/683
(100 %)
0 diff
(100 %id)
R72913 breast .b 3605 to 3982 1 to 380   fully sequenced,   380/380
(100 %)
2 diff
(99.5 %id)
CA447808 Chondrosarcoma, Left Pelvis .b 3619 to 4286 686 to 19   AAA   668/668
(100 %)
1 diff
(99.9 %id)
BQ019299 lung, Metastatic Chondrosarcoma .b 3636 to 4291 674 to 19   tiling clone, AAA   656/656
(100 %)
0 diff
(100 %id)
BU626079 cell lines, Enchondroma .b 3644 to 4286 661 to 19   AAA   643/643
(100 %)
0 diff
(100 %id)
CA425006 cell lines, Chondrosarcoma .b 3648 to 4286 657 to 19   AAA   639/639
(100 %)
0 diff
(100 %id)
EC474068 Prostate .b 3655 to 3759 107 to 4       104/107
(97 %)
0 diff
(100 %id)
EC566516 Prostate .b 3655 to 3760 104 to 2       103/104
(99 %)
0 diff
(100 %id)
AW375330 colon .b 3667 to 3881 231 to 8       224/231
(96 %)
0 diff
(100 %id)
BM715381 eye, human retina .b 3667 to 4286 1 to 620   AAA   620/620
(100 %)
0 diff
(100 %id)
BM725631 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 3669 to 4286 1 to 618   AAA   618/618
(100 %)
0 diff
(100 %id)
CB851600 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 3673 to 4286 632 to 19   AAA   614/614
(100 %)
0 diff
(100 %id)
FN072381 breast carcinoma .b 3675 to 3760 87 to 1     Submitted on the opposite strand 87/88
(98 %)
1 diff
(98.9 %id)
CX782860 human embryonic stem cells .b 3692 to 4286 620 to 26   AAA   595/595
(100 %)
2 diff
(99.7 %id)
CA449511 Chondrosarcoma, Left Pelvis .b 3692 to 4286 613 to 19   AAA   595/595
(100 %)
0 diff
(100 %id)
BM694912 eye, RPE and Choroid .b 3693 to 3864 1 to 172   fully sequenced,   172/172
(100 %)
0 diff
(100 %id)
BI058669 placenta_normal .b 3728 to 4261 555 to 23       533/555
(96 %)
0 diff
(100 %id)
BF771623 epid_tumor .b 3736 to 4139 425 to 21     Submitted on the opposite strand 405/425
(95 %)
0 diff
(100 %id)
EC485788 Prostate .b 3736 to 3843 108 to 1       108/108
(100 %)
2 diff
(98.2 %id)
BM668606 eye, Retina Foveal and Macular .b 3751 to 4286 554 to 19   fully sequenced, AAA   536/536
(100 %)
0 diff
(100 %id)
BF892302 marrow .b 3771 to 4246 490 to 16     Submitted on the opposite strand 475/490
(96 %)
0 diff
(100 %id)
BP392165 pancreatic islet .b 3790 to 4286 1 to 497     Submitted on the opposite strand 497/497
(100 %)
5 diff
(99.0 %id)
FN051137 breast carcinoma .b 3796 to 3863 68 to 1     Submitted on the opposite strand 68/69
(98 %)
0 diff
(100 %id)
AA579527   .b 3800 to 3890 1 to 91       91/91
(100 %)
8 diff
(91.3 %id)
AA044737 uterus .b 3809 to 4286 469 to 1   fully sequenced,   469/469
(100 %)
0 diff
(100 %id)
AW571843 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 3817 to 4287 471 to 1       471/471
(100 %)
0 diff
(100 %id)
DB541669 hippocampus .b 3827 to 4286 1 to 460     Submitted on the opposite strand 460/460
(100 %)
3 diff
(99.4 %id)
DB575327 hypothalamus .b 3827 to 4286 1 to 460     Submitted on the opposite strand 460/460
(100 %)
7 diff
(98.5 %id)
AA464259 ovarian tumor, ovary .b 3829 to 4287 459 to 1       459/459
(100 %)
4 diff
(99.2 %id)
AI141437 heart .b 3831 to 4286 456 to 1       456/456
(100 %)
0 diff
(100 %id)
BU731714 eye, RPE and Choroid .b 3834 to 4286 471 to 19   fully sequenced, AAA   453/453
(100 %)
0 diff
(100 %id)
AI149284 placenta .b 3835 to 4286 452 to 1       452/452
(100 %)
0 diff
(100 %id)
BU736782 eye, RPE and Choroid .b 3858 to 4286 448 to 19   fully sequenced, AAA   430/430
(100 %)
0 diff
(100 %id)
AI305836 2 pooled tumors (clear cell type), Kidney .b 3867 to 4286 435 to 16   AAA   420/420
(100 %)
0 diff
(100 %id)
AA524083 colon .b 3885 to 4287 403 to 1       403/403
(100 %)
0 diff
(100 %id)
AJ708810 heart .b 3891 to 4267 379 to 3     Submitted on the opposite strand 377/379
(99 %)
0 diff
(100 %id)
BF814648 colon_ins .b 3910 to 4270 377 to 17     Submitted on the opposite strand 361/377
(95 %)
0 diff
(100 %id)
AI146671 pooled germ cell tumors .b 3916 to 4288 373 to 1       373/373
(100 %)
0 diff
(100 %id)
AI244899 Kidney .b 3917 to 4286 383 to 14   AAA   370/370
(100 %)
0 diff
(100 %id)
BM725274 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 3922 to 4286 1 to 365   AAA   365/365
(100 %)
0 diff
(100 %id)
AI076063 B-cell, chronic lymphotic leukemia .b 3939 to 4287 349 to 1       349/349
(100 %)
0 diff
(100 %id)
AI354608 Kidney, renal cell tumor .b 3946 to 4286 354 to 14   AAA   341/341
(100 %)
0 diff
(100 %id)
TI_154139714   .b 3950 to 4287 80 to 417       338/832
(40 %)
2 diff
(99.8 %id)
R73545 breast .b 3952 to 4286 336 to 1   fully sequenced,   336/336
(100 %)
4 diff
(98.9 %id)
BP392059 pancreatic islet .b 3971 to 4286 1 to 316     Submitted on the opposite strand 316/316
(100 %)
0 diff
(100 %id)
AI284249 Kidney .b 3993 to 4246 254 to 1       254/254
(100 %)
0 diff
(100 %id)
CR985045 T-Lymphocytes .b 3994 to 4286 1 to 293   AAA   293/293
(100 %)
0 diff
(100 %id)
AA285029 ovarian tumor, ovary .b 4022 to 4289 302 to 35   AAA   268/268
(100 %)
0 diff
(100 %id)
FN112803 breast carcinoma .b 4038 to 4142 107 to 1     Submitted on the opposite strand 107/107
(100 %)
2 diff
(98.2 %id)
FN061803 breast carcinoma .b 4092 to 4153 63 to 1     Submitted on the opposite strand 63/64
(98 %)
1 diff
(98.5 %id)
BM932328 pooled colon, kidney, stomach .b 4097 to 4286 1 to 190   AAA   190/190
(100 %)
0 diff
(100 %id)
FN119856 breast carcinoma .b 4152 to 4229 79 to 4     Submitted on the opposite strand 76/80
(95 %)
0 diff
(100 %id)
AA479659 ovarian tumor, ovary .b 4157 to 4287 131 to 1       131/131
(100 %)
0 diff
(100 %id)
AI802293   .b 4160 to 4286 127 to 1       127/128
(99 %)
0 diff
(100 %id)
FN055091 breast carcinoma .b 4168 to 4250 1 to 83       83/83
(100 %)
0 diff
(100 %id)
AW000776 colon, colonic mucosa from 3 patients with Crohn'sdisease .b 4190 to 4282 93 to 1       93/95
(97 %)
5 diff
(94.8 %id)
BE223013 brain, oligodendroglioma .b 4202 to 4286 85 to 1       85/85
(100 %)
0 diff
(100 %id)
GD154776   .b 4209 to 4286 1 to 79   AAA   79/79
(100 %)
3 diff
(96.3 %id)
EC465934 Prostate .b 4226 to 4286 60 to 1       60/112
(53 %)
1 diff
(99.2 %id)
AY358566   .c 1 to 1918 1 to 1918 exact tiling clone, AAA   1918/1918
(100 %)
1 diff
(100.0 %id)
NM_144683.3   .c 1 to 1919 1 to 1919 exact RefSeq, AAA   1919/1919
(100 %)
0 diff
(100 %id)
AL555292 placenta .c 2 to 951 1 to 940   fully sequenced,   940/940
(100 %)
9 diff
(99.1 %id)
BX418841 brain, fetal brain .c 5 to 956 1 to 942       942/952
(98 %)
18 diff
(98.2 %id)
BI917332 brain .c 5 to 872 1 to 887       887/888
(99 %)
37 diff
(95.9 %id)
TI_57244622   .c 5 to 872 38 to 924       887/925
(95 %)
37 diff
(96.0 %id)
BX447717 T cells (Jurkat cell line) .c 7 to 914 1 to 906       906/919
(98 %)
22 diff
(97.7 %id)
BQ637032 eye, retina .c 8 to 545 1 to 538       538/538
(100 %)
16 diff
(97.1 %id)
AX795343   .c 10 to 862 1 to 853       853/853
(100 %)
2 diff
(99.8 %id)
AX795346   .c 60 to 816 1 to 764       764/782
(97 %)
15 diff
(98.1 %id)
BI764459 pooled colon, kidney, stomach .c 60 to 816 1 to 764       764/782
(97 %)
15 diff
(98.1 %id)
TI_57152564   .c 60 to 816 58 to 821       764/839
(91 %)
16 diff
(98.1 %id)
CR595762 T cells (Jurkat cell line) .c 104 to 1867 1 to 1764 exact     1764/1764
(100 %)
0 diff
(100 %id)
BX459294 placenta .c 104 to 990 1 to 872       872/961
(90 %)
22 diff
(97.8 %id)
AL557231 T cells (Jurkat cell line), T cells from T cell leukemia .c 104 to 995 1 to 880   fully sequenced,   880/880
(100 %)
8 diff
(99.1 %id)
CB991212 placenta, pre-eclamptic placenta .c 105 to 623 28 to 543       516/576
(89 %)
10 diff
(98.3 %id)
AL560611 B cells from Burkitt lymphoma .c 110 to 1070 1 to 949   fully sequenced,   949/949
(100 %)
25 diff
(97.4 %id)
CN430032 embryonic stem cells, cell lines H1, H7, andH9 .c 117 to 613 1 to 497       497/497
(100 %)
0 diff
(100 %id)
AX795339   .c 119 to 1014 1 to 893       893/893
(100 %)
6 diff
(99.4 %id)
CR591219 Neuroblastoma Cot 25-normalized .c 123 to 1864 1 to 1742 exact     1742/1742
(100 %)
0 diff
(100 %id)
CR598291 B cells (Ramos cell line) Cot 25-normalized .c 123 to 1860 1 to 1738 exact     1738/1738
(100 %)
0 diff
(100 %id)
AL527763 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 123 to 905 1 to 779   fully sequenced,   779/779
(100 %)
5 diff
(99.4 %id)
AL583126 B cells from Burkitt lymphoma .c 123 to 1005 1 to 866       866/964
(89 %)
18 diff
(98.2 %id)
CR597091 HeLa cells Cot 25-normalized .c 124 to 1888 1 to 1765 exact     1765/1765
(100 %)
0 diff
(100 %id)
AL556009 placenta .c 124 to 985 1 to 855   fully sequenced,   855/855
(100 %)
2 diff
(99.8 %id)
AX795341   .c 125 to 975 1 to 850       850/850
(100 %)
9 diff
(99.0 %id)
DR002206 fetal brain .c 125 to 886 1 to 762       762/762
(100 %)
4 diff
(99.5 %id)
CR983741 T-Lymphocytes .c 127 to 650 1 to 524       524/524
(100 %)
0 diff
(100 %id)
CA488817   .c 129 to 815 1 to 688       688/918
(74 %)
16 diff
(98.3 %id)
AX795338   .c 131 to 1096 1 to 966       966/966
(100 %)
9 diff
(99.1 %id)
AX795342   .c 131 to 1005 1 to 858       858/936
(91 %)
18 diff
(98.1 %id)
AX795340   .c 132 to 1009 1 to 874       874/874
(100 %)
6 diff
(99.4 %id)
AX795345   .c 133 to 939 11 to 838       828/860
(96 %)
31 diff
(96.4 %id)
BI912166 leukocyte .c 133 to 939 11 to 838       828/860
(96 %)
31 diff
(96.4 %id)
BM914621 Spleen .c 133 to 883 1 to 754       754/1058
(71 %)
10 diff
(99.1 %id)
TI_57233680   .c 133 to 939 11 to 838       828/860
(96 %)
31 diff
(96.4 %id)
BU187307 eye, retinoblastoma .c 135 to 923 1 to 794       794/931
(85 %)
12 diff
(98.8 %id)
AX795344   .c 167 to 913 1 to 745       745/856
(87 %)
16 diff
(98.2 %id)
BF569227 Kidney, renal carcinoma (ascites) .c 167 to 913 1 to 745       745/856
(87 %)
16 diff
(98.2 %id)
CV028931 mixed .c 278 to 855 1 to 578       578/578
(100 %)
0 diff
(100 %id)
TI_1948091332   .c 278 to 1249 134 to 1106       973/1282
(75 %)
30 diff
(97.7 %id)
TI_1948091447   .c 278 to 1255 136 to 1116   fully sequenced,   981/1116
(87 %)
47 diff
(95.8 %id)
TI_1948091571   .c 278 to 1263 130 to 1112       983/1275
(77 %)
37 diff
(97.1 %id)
TI_1948091693   .c 278 to 1179 136 to 1036       901/1279
(70 %)
29 diff
(97.8 %id)
AX795363   .c 393 to 940 9 to 556       548/556
(98 %)
6 diff
(99.0 %id)
BI710807 insulinoma, Pancreas .c 393 to 940 9 to 556       548/556
(98 %)
6 diff
(99.0 %id)
CK820457 insulinoma, Pancreas .c 393 to 919 9 to 535       527/535
(98 %)
5 diff
(99.1 %id)
BU579885 insulinoma, Pancreas .c 393 to 909 9 to 526       518/526
(98 %)
6 diff
(98.9 %id)
CX872070 embryonic stem .c 398 to 892 1 to 495       495/495
(100 %)
3 diff
(99.4 %id)
AX795365   .c 480 to 816 1 to 338       338/352
(96 %)
6 diff
(98.3 %id)
AW962021   .c 481 to 1112 1 to 630       630/652
(96 %)
19 diff
(97.1 %id)
AX795361   .c 481 to 1112 1 to 630       630/652
(96 %)
19 diff
(97.1 %id)
CN430033 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 481 to 1113 12 to 643       632/643
(98 %)
6 diff
(99.1 %id)
AX795358   .c 629 to 1409 1 to 777       777/849
(91 %)
25 diff
(97.1 %id)
BF337668 brain, glioblastoma with EGFR amplification .c 629 to 1409 1 to 777       777/849
(91 %)
25 diff
(97.1 %id)
CX787076 human embryonic stem cells .c 665 to 1412 1 to 748       748/748
(100 %)
1 diff
(99.9 %id)
BF344885 brain, glioblastoma with EGFR amplification .c 741 to 1191 1 to 453       453/1199
(37 %)
7 diff
(99.5 %id)
AL527762 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 875 to 1864 977 to 1   fully sequenced,   977/977
(100 %)
10 diff
(99.0 %id)
AL577831 placenta .c 921 to 1890 962 to 1   fully sequenced,   962/962
(100 %)
14 diff
(98.6 %id)
TI_1948091448   .c 943 to 1268 447 to 122   fully sequenced,   326/447
(72 %)
5 diff
(98.9 %id)
AL578375 placenta .c 955 to 1869 925 to 18   fully sequenced,   908/925
(98 %)
8 diff
(99.2 %id)
AL579309 T cells (Jurkat cell line), T cells from T cell leukemia .c 965 to 1867 894 to 1   fully sequenced,   894/894
(100 %)
11 diff
(98.8 %id)
BX447716 T cells (Jurkat cell line) .c 975 to 1891 932 to 17       916/932
(98 %)
0 diff
(100 %id)
BX412517 placenta .c 1030 to 1918 885 to 1   tiling clone,   885/892
(99 %)
13 diff
(98.6 %id)
AL582023 B cells from Burkitt lymphoma .c 1040 to 1889 834 to 1   fully sequenced,   834/834
(100 %)
23 diff
(97.3 %id)
BX454874 brain, fetal brain .c 1043 to 1917 875 to 1       875/876
(99 %)
11 diff
(98.8 %id)
BF570204 Kidney, renal carcinoma (ascites) .c 1113 to 1845 755 to 23       733/990
(74 %)
0 diff
(100 %id)
BU579644 insulinoma, Pancreas .c 1370 to 1918 571 to 23   AAA   549/549
(100 %)
1 diff
(99.9 %id)
CR979104 T-Lymphocytes .d 1 to 509 1 to 509   tiling clone,   509/514
(99 %)
1 diff
(99.9 %id)
AX795336   .d 102 to 719 1 to 617       617/617
(100 %)
1 diff
(99.9 %id)
AX795335   .d 104 to 724 1 to 621       621/621
(100 %)
2 diff
(99.7 %id)
BE019444 muscle, rhabdomyosarcoma .d 104 to 724 1 to 621       621/621
(100 %)
2 diff
(99.7 %id)
AX795337   .d 115 to 741 1 to 631       631/631
(100 %)
7 diff
(98.9 %id)
BC015582 Lung, large cell carcinoma .d 116 to 2023 1 to 1908 exact tiling clone, available from MGC, AAA   1908/1908
(100 %)
0 diff
(100 %id)
BM722228 eye, fetal eye .d 128 to 720 1 to 593       593/593
(100 %)
0 diff
(100 %id)
CR617686 B cells (Ramos cell line) Cot 25-normalized .d 298 to 1994 1 to 1697 exact     1697/1697
(100 %)
0 diff
(100 %id)
BE208014 muscle, rhabdomyosarcoma .d 1581 to 2024 455 to 12   tiling clone, AAA   444/444
(100 %)
1 diff
(99.8 %id)
BU740084 eye, fetal eye .d 1618 to 2023 424 to 19   AAA   406/406
(100 %)
3 diff
(99.3 %id)
TI_57147535   .e 1 to 811 105 to 921 V34A D244G Y245L L246S S247E ... tiling clone,   817/921
(88 %)
17 diff
(98.2 %id)
BU517226 leiomyosarcoma, uterus .f 1 to 703 1 to 710 G171X A187X E188R E197G A198S ... tiling clone, AAA   710/776
(91 %)
18 diff
(97.7 %id)
BM557876 astrocytoma grade IV, cell line, brain .g 1 to 882 6 to 893 exact tiling clone,   893/1035
(86 %)
11 diff
(99.0 %id)
BF857397 prostate_tumor .h 1 to 150 151 to 1   tiling clone, Submitted on the opposite strand 151/153
(98 %)
12 diff
(92.2 %id)
DB455265.
matches multiple genes
testis .h 109 to 576 1 to 468   tiling clone, also hits gene muror 468/468
(100 %)
1 diff
(99.8 %id)
BM924820 pooled colon, kidney, stomach .h 522 to 1512 1 to 1000   tiling clone,   1000/1117
(89 %)
22 diff
(98.1 %id)
CD637130   .h 527 to 1392 10 to 876       867/876
(98 %)
6 diff
(99.4 %id)
AL583125 B cells from Burkitt lymphoma .h 552 to 1557 1002 to 1       1002/1047
(95 %)
11 diff
(99.0 %id)
AX795356   .h 560 to 1405 1 to 847       847/1093
(77 %)
37 diff
(96.7 %id)
BG033859 breast, mammary adenocarcinoma, cell line .h 560 to 1405 1 to 847       847/1093
(77 %)
37 diff
(96.7 %id)
AX795359   .h 628 to 1363 1 to 729       729/800
(91 %)
14 diff
(98.3 %id)
BF527195 anaplastic oligodendroglioma with 1p/19qloss, brain .h 628 to 1363 1 to 729       729/800
(91 %)
14 diff
(98.3 %id)
BP332160 renal proximal tubule .h 631 to 1206 1 to 576       576/582
(98 %)
7 diff
(98.8 %id)
BX328355   .h 636 to 1539 16 to 920       905/920
(98 %)
6 diff
(99.4 %id)
AA322599 brain, cerebellum .h 651 to 937 1 to 287       287/287
(100 %)
0 diff
(100 %id)
AX795362   .h 666 to 1000 1 to 335       335/335
(100 %)
5 diff
(98.6 %id)
AX795369   .h 686 to 933 1 to 248       248/248
(100 %)
3 diff
(98.8 %id)
AA112477 Pancreas .h 686 to 933 1 to 248       248/248
(100 %)
3 diff
(98.8 %id)
R91331 liver and spleen .h 688 to 1161 1 to 485       485/485
(100 %)
17 diff
(96.5 %id)
BX097334 liver and spleen .h 695 to 1400 1 to 706       706/706
(100 %)
0 diff
(100 %id)
AX795366   .h 696 to 1182 1 to 477       477/477
(100 %)
8 diff
(98.4 %id)
W03277 liver and spleen .h 696 to 1182 1 to 477       477/477
(100 %)
8 diff
(98.4 %id)
BU655852 blood .h 758 to 1380 11 to 633       623/633
(98 %)
6 diff
(99.1 %id)
AX795368   .h 771 to 1038 1 to 268       268/268
(100 %)
2 diff
(99.3 %id)
AA236335 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 771 to 1038 1 to 268       268/268
(100 %)
2 diff
(99.3 %id)
BP431726   .h 779 to 1156 1 to 378       378/378
(100 %)
0 diff
(100 %id)
TI_154112239   .h 829 to 1615 863 to 84   AAA   780/928
(84 %)
17 diff
(98.2 %id)
BQ052759 blood, natural killer cells, cell line .h 878 to 1616 1 to 740   AAA   740/740
(100 %)
1 diff
(99.9 %id)
BU165250 eye, retinoblastoma .h 895 to 1615 1 to 722       722/725
(99 %)
2 diff
(99.8 %id)
AX795367   .h 905 to 1387 1 to 489       489/491
(99 %)
10 diff
(98.0 %id)
H79605 liver and spleen .h 905 to 1332 1 to 434   fully sequenced,   434/434
(100 %)
5 diff
(98.9 %id)
H71720 liver and spleen .h 906 to 1288 1 to 384       384/384
(100 %)
1 diff
(99.8 %id)
CA431081 cell lines, Chondrosarcoma .h 956 to 1615 678 to 19   AAA   660/660
(100 %)
1 diff
(99.9 %id)
CB529160 Aveolar Macrophage, lung .h 957 to 1616 678 to 19   AAA   660/660
(100 %)
1 diff
(99.9 %id)
CA448556 Chondrosarcoma, Left Pelvis .h 959 to 1615 675 to 19   AAA   657/657
(100 %)
1 diff
(99.9 %id)
BU619520 Cell Line, Chondrosarcoma .h 962 to 1615 672 to 19   AAA   654/654
(100 %)
1 diff
(99.9 %id)
BQ349821 head_neck .h 1000 to 1429 1 to 431       431/431
(100 %)
29 diff
(93.3 %id)
DA105426 cerebellum .h 1002 to 1490 2 to 490   fully sequenced, capped   489/489
(100 %)
1 diff
(99.8 %id)
CA423524 cell lines, Chondrosarcoma .h 1076 to 1615 557 to 19   AAA   539/539
(100 %)
4 diff
(99.3 %id)
BU631400 cell lines, Chondrosarcoma .h 1076 to 1615 558 to 19   AAA   540/540
(100 %)
0 diff
(100 %id)
AI972891 Prostate .h 1085 to 1615 531 to 1       531/531
(100 %)
1 diff
(99.9 %id)
AI076793   .h 1090 to 1618 532 to 4       529/532
(99 %)
0 diff
(100 %id)
W76105 heart .h 1099 to 1202 1 to 104   fully sequenced,   104/104
(100 %)
1 diff
(99.1 %id)
BG149697 carcinoid, lung .h 1161 to 1618 461 to 4       458/461
(99 %)
0 diff
(100 %id)
BE549951 carcinoid, lung .h 1163 to 1615 455 to 3       453/455
(99 %)
0 diff
(100 %id)
AW770937 carcinoid, lung .h 1164 to 1615 454 to 3       452/454
(99 %)
0 diff
(100 %id)
BF110354 carcinoid, lung .h 1164 to 1618 458 to 4       455/458
(99 %)
0 diff
(100 %id)
AI565789 anaplastic oligodendroglioma, brain .h 1166 to 1618 456 to 4       453/456
(99 %)
0 diff
(100 %id)
BG056175 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .h 1167 to 1615 455 to 2       454/455
(99 %)
0 diff
(100 %id)
AI862125 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .h 1168 to 1618 457 to 7       451/457
(98 %)
0 diff
(100 %id)
AI361692 anaplastic oligodendroglioma, brain .h 1170 to 1618 449 to 1   tiling clone,   449/449
(100 %)
0 diff
(100 %id)
W72591 heart .h 1172 to 1617 446 to 1   fully sequenced,   446/446
(100 %)
5 diff
(98.9 %id)
AI369826 anaplastic oligodendroglioma, brain .h 1176 to 1618 443 to 1       443/443
(100 %)
1 diff
(99.8 %id)
AW606005 head_neck .h 1191 to 1370 1 to 175       175/178
(98 %)
12 diff
(93.3 %id)
AI458113 pooled .h 1193 to 1616 435 to 13   AAA   423/423
(100 %)
2 diff
(99.6 %id)
AW578714 colon .h 1195 to 1616 5 to 422       418/423
(98 %)
22 diff
(94.8 %id)
AW370953 breast .h 1196 to 1616 1 to 419       419/420
(99 %)
14 diff
(96.7 %id)
AI565656 anaplastic oligodendroglioma, brain .h 1199 to 1615 418 to 2       417/418
(99 %)
0 diff
(100 %id)
AW370951 breast .h 1201 to 1616 1 to 417       417/418
(99 %)
6 diff
(98.6 %id)
N69449 liver and spleen .h 1201 to 1615 432 to 19   AAA   414/416
(99 %)
3 diff
(99.3 %id)
AA112478 Pancreas .h 1205 to 1615 413 to 2       412/413
(99 %)
0 diff
(100 %id)
BE698067 uterus_tumor .h 1208 to 1463 1 to 256       256/256
(100 %)
5 diff
(98.1 %id)
AW370952 breast .h 1210 to 1616 1 to 406       406/420
(96 %)
12 diff
(97.2 %id)
AW370945 breast .h 1219 to 1616 1 to 398       398/399
(99 %)
9 diff
(97.8 %id)
R91290 liver and spleen .h 1228 to 1618 403 to 9       395/411
(96 %)
0 diff
(100 %id)
AA417749 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1248 to 1600 1 to 352       352/352
(100 %)
1 diff
(99.8 %id)
AX795352   .h 1255 to 1611 1 to 357       357/357
(100 %)
0 diff
(100 %id)
AA773410 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1255 to 1611 1 to 357       357/357
(100 %)
0 diff
(100 %id)
BM723208 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 1257 to 1615 1 to 359   AAA   359/359
(100 %)
0 diff
(100 %id)
AW014942   .h 1260 to 1615 373 to 18   AAA   356/356
(100 %)
2 diff
(99.5 %id)
EC553335 Prostate .h 1269 to 1374 1 to 106       106/106
(100 %)
1 diff
(99.1 %id)
EC494846 Prostate .h 1270 to 1374 1 to 105       105/105
(100 %)
0 diff
(100 %id)
EC538565 Prostate .h 1270 to 1374 1 to 102       102/102
(100 %)
4 diff
(96.1 %id)
EC584676 Prostate .h 1298 to 1411 1 to 110       110/110
(100 %)
8 diff
(92.8 %id)
EC585067 Prostate .h 1299 to 1411 1 to 110       110/110
(100 %)
6 diff
(94.6 %id)
H79606 liver and spleen .h 1302 to 1594 295 to 1   fully sequenced,   295/295
(100 %)
2 diff
(99.4 %id)
BF593346 Prostate .h 1314 to 1615 314 to 13   AAA   302/302
(100 %)
4 diff
(98.7 %id)
AI420259 Prostate .h 1315 to 1615 314 to 14   AAA   301/301
(100 %)
3 diff
(99.1 %id)
AI675851 Prostate .h 1315 to 1615 313 to 13   AAA   301/301
(100 %)
0 diff
(100 %id)
T23807   .h 1321 to 1618 299 to 2       298/299
(99 %)
0 diff
(100 %id)
BE165454 head_neck .h 1322 to 1500 17 to 193       177/193
(91 %)
6 diff
(96.9 %id)
AI696353 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .h 1330 to 1615 299 to 12   AAA   288/288
(100 %)
5 diff
(98.3 %id)
R45437 whole brain .h 1337 to 1615 301 to 20   AAA   282/283
(99 %)
4 diff
(98.6 %id)
AI474427 Prostate .h 1338 to 1615 320 to 43   AAA   278/278
(100 %)
16 diff
(94.3 %id)
BE165443 head_neck .h 1342 to 1500 18 to 174       157/174
(90 %)
6 diff
(96.6 %id)
AI695166 colon .h 1355 to 1618 265 to 2       264/265
(99 %)
0 diff
(100 %id)
AW370993 breast .h 1364 to 1616 1 to 253       253/254
(99 %)
14 diff
(94.5 %id)
AI682500 Prostate .h 1388 to 1615 252 to 25   AAA   228/228
(100 %)
5 diff
(97.9 %id)
AA773411 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1389 to 1606 1 to 218       218/218
(100 %)
0 diff
(100 %id)
AI693959 colon .h 1399 to 1617 219 to 1       219/219
(100 %)
0 diff
(100 %id)
AI146575 brain, glioblastoma (pooled) .h 1427 to 1618 192 to 1       192/192
(100 %)
0 diff
(100 %id)
AW084416 esophagus, squamous cell carcinoma .h 1454 to 1600 147 to 1       147/147
(100 %)
2 diff
(98.7 %id)
AA236241 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1459 to 1616 175 to 19   AAA   157/157
(100 %)
1 diff
(99.4 %id)
DB299461 cerebellum .h 1460 to 1615 156 to 1   fully sequenced,   156/156
(100 %)
1 diff
(99.4 %id)
AL045310 testis .i 1 to 429 1 to 429   tiling clone,   429/429
(100 %)
0 diff
(100 %id)
AI380864 B-cell, chronic lymphotic leukemia .i 403 to 668 266 to 1   tiling clone,   266/266
(100 %)
0 diff
(100 %id)
H56230 liver and spleen .j 1 to 344 1 to 345 G16L N17E N18Q E19* tiling clone,   345/356
(96 %)
10 diff
(97.2 %id)
BM926735 brain .k 1 to 434 12 to 446 exact tiling clone,   435/1183
(36 %)
14 diff
(98.9 %id)
BM544268 ovary (pool of 3) .l 1 to 606 18 to 622 A7V D8T P9R L10C L11C ... tiling clone,   605/1178
(51 %)
21 diff
(98.3 %id)
BE720079 head_neck .m 1 to 166 1 to 167 Q36H I37D Y38L Q39S D40G ... tiling clone,   167/168
(99 %)
8 diff
(95.3 %id)
BQ716645 sympathetic trunk .n-u 477 to 966 1 to 496   tiling clone,   496/1032
(48 %)
38 diff
(96.4 %id)
BG012192 placenta_normal .o-u 1 to 300 1 to 311 W38X S39W V41S E42V T43E ... tiling clone,   311/312
(99 %)
5 diff
(98.4 %id)
BI010618 lung_normal .o-u 1 to 300 1 to 311 W38X S39W V41S E42V T43E ...     311/312
(99 %)
5 diff
(98.4 %id)
BE244032 leukopheresis Gene DHRS13andFLOT2, variant not shown              
BE245028 leukopheresis Gene DHRS13andFLOT2, variant not shown              
EC567888 Prostate Gene DHRS13andFLOT2, variant not shown         This clone was ignored    
EC536967 Prostate Gene DHRS13andFLOT2, variant not shown         This clone was ignored    
EC509865 Prostate Gene DHRS13andFLOT2, variant not shown         This clone was ignored    
EC513548 Prostate Gene DHRS13andFLOT2, variant not shown         This clone was ignored    
TI_1948124224   Gene DHRS13andFLOT2, variant not shown         This clone was ignored    
TI_1948124225   Gene DHRS13andFLOT2, variant not shown         This clone was ignored    
TI_1948124226   Gene DHRS13andFLOT2, variant not shown         This clone was ignored    
TI_1948124745   Gene DHRS13andFLOT2, variant not shown         This clone was ignored    
TI_1948124746   Gene DHRS13andFLOT2, variant not shown         This clone was ignored    
TI_1948124747   Gene DHRS13andFLOT2, variant not shown         This clone was ignored    
TI_1948125284   Gene DHRS13andFLOT2, variant not shown         This clone was ignored    
TI_1948125285   Gene DHRS13andFLOT2, variant not shown         This clone was ignored    
TI_1948125286   Gene DHRS13andFLOT2, variant not shown         This clone was ignored    
TI_1948125813   Gene DHRS13andFLOT2, variant not shown         This clone was ignored    
TI_1948125814   Gene DHRS13andFLOT2, variant not shown         This clone was ignored    
TI_1948125815   Gene DHRS13andFLOT2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n-u, .o-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI